Assessment of Degradability and Endothelialization of Modified Poly L-lactic Acid (PLLA) Atrial Septal Defect (ASD) Occluders over Time in Vivo

Overview

Journal J Cardiothorac Surg

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
General Surgery
Pulmonary Medicine

Date 2023 Oct 10

PMID 37817186

Authors

Jun Chen

Yumei Xie

Yifan Li

Xianmiao Chen

Mingjuan Fu

Yanfen Liu

Zhiwei Zhang

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the fiber-degradation and endothelialization of a modified poly L-lactic acid (PLLA) atrial septal defect (ASD) occluder for a long time in vivo.

Methods: A total of 57 New Zealand rabbits were selected to establish the vasculature implantation model, which would be used to characterize the mechanical properties and pathological reaction of PLLA filaments (a raw polymer of ASD occluder). In total, 27 Experimental piglets were used to create the ASD model for the catheter implantation of PLLA ASD occluders. Then, X-ray imaging, transthoracic echocardiography, histopathology, and scanning electron microscope (SEM) were performed in the experimental animals at 3, 6, 12, and 24 months after implantation.

Results: In the rabbit models, the fibrocystic grade was 0 and the inflammatory response was grade 2 at 6 months after vasculature implantation of the PLLA filaments. The mass loss of PLLA filaments increased appreciably with the increasing duration of implantation, but their mechanical strength was decreased without broken. In the porcine models, the cardiac gross anatomy showed that all PLLA ASD occluders were stable in the interatrial septum without any vegetation or thrombus formation. At 24 months, the occluders had been embedded into endogenous host tissue nearly. Pathological observations suggested that the occluders degraded gradually without complications at different periods. SEM showed that the occluders were endothelialized completely and essentially became an integral part of the body over time.

Conclusion: In the animal model, the modified PLLA ASD occluders exhibited good degradability and endothelialization in this long-term follow-up study.

References

Bissessor N . Current perspectives in percutaneous atrial septal defect closure devices. Med Devices (Auckl). 2015; 8:297-303. PMC: 4508077. DOI: 10.2147/MDER.S49368. View

Olasinska-Wisniewska A, Grygier M . Antithrombotic/Antiplatelet Treatment in Transcatheter Structural Cardiac Interventions-PFO/ASD/LAA Occluder and Interatrial Shunt Devices. Front Cardiovasc Med. 2019; 6:75. PMC: 6568033. DOI: 10.3389/fcvm.2019.00075. View

Lu W, Ouyang W, Wang S, Liu Y, Zhang F, Wang W . A novel totally biodegradable device for effective atrial septal defect closure: A 2-year study in sheep. J Interv Cardiol. 2018; 31(6):841-848. DOI: 10.1111/joic.12550. View

Shi D, Kang Y, Zhang G, Gao C, Lu W, Zou H . Biodegradable atrial septal defect occluders: A current review. Acta Biomater. 2019; 96:68-80. DOI: 10.1016/j.actbio.2019.05.073. View

Lu A, Petit E, Jelonek K, Orchel A, Kasperczyk J, Wang Y . Self-assembled micelles prepared from bio-based hydroxypropyl methyl cellulose and polylactide amphiphilic block copolymers for anti-tumor drug release. Int J Biol Macromol. 2020; 154:39-47. DOI: 10.1016/j.ijbiomac.2020.03.094. View

Cao S, Shao J, Xia Y, Che H, Zhong Z, Meng F . Molecular Programming of Biodegradable Nanoworms via Ionically Induced Morphology Switch toward Asymmetric Therapeutic Carriers. Small. 2019; 15(38):e1901849. DOI: 10.1002/smll.201901849. View

Evgenidou E, Ofrydopoulou A, Malesic-Eleftheriadou N, Nannou C, Ainali N, Christodoulou E . New insights into transformation pathways of a mixture of cytostatic drugs using Polyester-TiO films: Identification of intermediates and toxicity assessment. Sci Total Environ. 2020; 741:140394. DOI: 10.1016/j.scitotenv.2020.140394. View

Pacharra S, Ortiz R, McMahon S, Wang W, Viebahn R, Salber J . Surface patterning of a novel PEG-functionalized poly-l-lactide polymer to improve its biocompatibility: Applications to bioresorbable vascular stents. J Biomed Mater Res B Appl Biomater. 2018; 107(3):624-634. PMC: 6585964. DOI: 10.1002/jbm.b.34155. View

Liang X, Gao J, Xu W, Wang X, Shen Y, Tang J . Structural mechanics of 3D-printed poly(lactic acid) scaffolds with tetragonal, hexagonal and wheel-like designs. Biofabrication. 2019; 11(3):035009. DOI: 10.1088/1758-5090/ab0f59. View

10.

Vahl T, Gasior P, Gongora C, Ramzipoor K, Lee C, Cheng Y . Four-year polymer biocompatibility and vascular healing profile of a novel ultrahigh molecular weight amorphous PLLA bioresorbable vascular scaffold: an OCT study in healthy porcine coronary arteries. EuroIntervention. 2016; 12(12):1510-1518. DOI: 10.4244/EIJ-D-16-00308. View

12.

Xie Z, Wang S, Zhang Z, Zhuang J, Liu X, Chen X . A Novel-Design Poly-L-Lactic Acid Biodegradable Device for Closure of Atrial Septal Defect: Long-Term Results in Swine. Cardiology. 2016; 135(3):179-187. DOI: 10.1159/000446313. View

13.

Masura J, Gavora P, Formanek A, Hijazi Z . Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn. 1997; 42(4):388-93. DOI: 10.1002/(sici)1097-0304(199712)42:4<388::aid-ccd7>3.0.co;2-7. View

14.

Pranata R, Yonas E, Deka H, Vania R, July J . Stent-Assisted Coiling of Intracranial Aneurysms Using a Nitinol-Based Stent (Neuroform Atlas): A Systematic Review and Meta-analysis. Cardiovasc Intervent Radiol. 2020; 43(7):1049-1061. DOI: 10.1007/s00270-020-02502-9. View

15.

Dhondt E, Vanlangenhove P, De Man M, Huyck L, Defreyne L . No Advantage of Expanded Polytetrafluoroethylene and Fluorinated Ethylene Propylene-Covered Stents over Uncovered Nitinol Stents for Percutaneous Palliation of Malignant Infrahilar Biliary Obstruction: Results of a Single-Center Prospective.... J Vasc Interv Radiol. 2019; 31(1):82-92. DOI: 10.1016/j.jvir.2019.07.013. View

16.

Lin C, Liu L, Liu Y, Leng J . Recent developments in next-generation occlusion devices. Acta Biomater. 2021; 128:100-119. DOI: 10.1016/j.actbio.2021.04.050. View

17.

Esmaeili A, Behnke-Hall K, Schrewe R, Schranz D . Percutaneous closure of perimembranous ventricular septal defects utilizing almost ideal Amplatzer Duct Occluder II: Why limitation in sizes?. Congenit Heart Dis. 2018; 14(3):389-395. DOI: 10.1111/chd.12731. View

18.

Fabi S, Weiss R, Weinkle S . Absorbable Suspension Sutures: Recommendations for Use in a Multimodal Nonsurgical Approach to Facial Rejuvenation. J Drugs Dermatol. 2021; 20(1):23-29. DOI: 10.36849/JDD.5684. View

19.

Hasan A, Soliman S, El Hajj F, Tseng Y, Yalcin H, Marei H . Fabrication and In Vitro Characterization of a Tissue Engineered PCL-PLLA Heart Valve. Sci Rep. 2018; 8(1):8187. PMC: 5974353. DOI: 10.1038/s41598-018-26452-y. View

20.

Wu W, Li B, Liu Y, Wang X . [Biodegradation properties of multi-laminated small intestinal submucosa]. Beijing Da Xue Xue Bao Yi Xue Ban. 2020; 52(3):564-569. PMC: 7433422. DOI: 10.19723/j.issn.1671-167X.2020.03.025. View

21.

Kian L, Saba N, Jawaid M, Sultan M . A review on processing techniques of bast fibers nanocellulose and its polylactic acid (PLA) nanocomposites. Int J Biol Macromol. 2018; 121:1314-1328. DOI: 10.1016/j.ijbiomac.2018.09.040. View